Suppr超能文献

缺血性脑卒中患者康复治疗后血清C反应蛋白水平变化的评估——一项回顾性观察研究

Assessment of Changes in Serum C-Reactive Protein Levels in Patients after Ischemic Stroke Undergoing Rehabilitation-A Retrospective Observational Study.

作者信息

Borowicz Wojciech, Ptaszkowski Kuba, Ptaszkowska Lucyna, Murawska-Ciałowicz Eugenia, Rosińczuk Joanna

机构信息

Department of Pediatric Infectious Diseases, Wroclaw Medical University, 50-368 Wroclaw, Poland.

Department of Nursing and Obstetrics, Wroclaw Medical University, 51-618 Wroclaw, Poland.

出版信息

J Clin Med. 2023 Jan 29;12(3):1029. doi: 10.3390/jcm12031029.

Abstract

Inflammation plays a key role in the pathogenesis and prognosis of ischemic stroke. C-reactive protein (CRP) is an inflammatory biomarker of inflammation and may reflect the progression of vascular disease. Using a biomarker such as CRP to predict recovery rather than mortality may present clinical value in providing rehabilitation. The primary aim of the study was to analyze changes in serum CRP levels in patients after ischemic stroke during the regenerative-compensatory period and to assess the usefulness of CRP as a potential biomarker during the rehabilitation period. The project was carried out as a retrospective analysis of prospectively collected data from post-stroke patients from the Department of Neurological Rehabilitation of the Regional Specialist Hospital in Wrocław. A group of 52 patients, after their first-ever ischemic stroke with subsequent hemiplegia, was finally qualified to participate in the study. Serum CRP levels were determined during blood laboratory tests. The Modified Rankin Scale (mRS) and Barthel Index (BI) were used to assess functional outcomes. Rehabilitation using neurophysiological methods was applied five days a week (each session lasted 60 min, and the entire period was 42 days). At the first test, serum CRP levels were found to be above 5 mg/L in 19 patients, the second test in 12 patients, the third test in five patients, and the fourth test in 9 patients. Only three patients had values higher than 5 mg/L in all consecutive assessments ( > 0.05). There was a statistically significant increase in BI scores after therapy ( < 0.001) as well as a decrease in the mRS score by 2.2 points ( < 0.001), in CRP values by 5.02 mg/L ( = 0.019), and in cortisol levels by 2.5 nmol/L ( = 0.002). Statistically significant relationships were observed between the CRP levels after rehabilitation and the corresponding mRS scores (rs = 0.29, = 0.038). Furthermore, the effect of BMI on CRP levels was demonstrated (B = 0.20, = 0.038). In conclusion, despite demonstrating a significant relationship between CRP levels and corresponding mRS scores, CRP levels alone may not serve as an independent predictor of long-term functional outcomes in ischemic stroke patients undergoing rehabilitation.

摘要

炎症在缺血性中风的发病机制和预后中起关键作用。C反应蛋白(CRP)是一种炎症生物标志物,可能反映血管疾病的进展。使用CRP等生物标志物来预测恢复情况而非死亡率,可能在提供康复治疗方面具有临床价值。本研究的主要目的是分析缺血性中风患者在再生代偿期血清CRP水平的变化,并评估CRP作为康复期潜在生物标志物的有用性。该项目是对弗罗茨瓦夫地区专科医院神经康复科中风后患者前瞻性收集的数据进行回顾性分析。一组52例首次发生缺血性中风并随后出现偏瘫的患者最终符合参与研究的条件。血清CRP水平在血液实验室检测时测定。采用改良Rankin量表(mRS)和Barthel指数(BI)评估功能结局。使用神经生理学方法进行康复治疗,每周5天(每次治疗持续60分钟,整个疗程为42天)。在第一次检测时,19例患者血清CRP水平高于5mg/L,第二次检测时有12例,第三次检测时有5例,第四次检测时有9例。只有3例患者在所有连续评估中值均高于5mg/L(>0.05)。治疗后BI评分有统计学显著增加(<0.001),mRS评分降低2.2分(<0.001),CRP值降低5.02mg/L(=0.019),皮质醇水平降低2.5nmol/L(=0.002)。康复后CRP水平与相应的mRS评分之间观察到统计学显著相关性(rs=0.29,=0.038)。此外,还证明了BMI对CRP水平的影响(B=0.20,=0.038)。总之,尽管CRP水平与相应的mRS评分之间存在显著关系,但单独的CRP水平可能无法作为接受康复治疗的缺血性中风患者长期功能结局的独立预测指标。

相似文献

5
Is there a correlation between hs-CRP levels and functional outcome of Ischemic Stroke?
Pak J Med Sci. 2013 Jan;29(1):166-9. doi: 10.12669/pjms.291.2799.
6
Clinical and biochemical predictors of late-outcome in patients after ischemic stroke.
Ann Agric Environ Med. 2020 Jun 19;27(2):290-294. doi: 10.26444/aaem/105927. Epub 2019 Apr 8.
7
C-reactive protein and long-term ischemic stroke prognosis.
J Clin Neurosci. 2014 Apr;21(4):547-53. doi: 10.1016/j.jocn.2013.06.015. Epub 2013 Aug 23.
8
The importance of selected markers of inflammation and blood-brain barrier damage for short-term ischemic stroke prognosis.
J Physiol Pharmacol. 2019 Apr;70(2). doi: 10.26402/jpp.2019.2.04. Epub 2019 Jul 22.

本文引用的文献

1
Diagnoses Based on C-Reactive Protein Point-of-Care Tests.
Biosensors (Basel). 2022 May 17;12(5):344. doi: 10.3390/bios12050344.
3
Comparison of responsiveness of the Barthel Index and modified Barthel Index in patients with stroke.
Disabil Rehabil. 2023 Mar;45(6):1097-1102. doi: 10.1080/09638288.2022.2055166. Epub 2022 Mar 31.
4
Using the Barthel Index and modified Rankin Scale as Outcome Measures for Stroke Rehabilitation Trials; A Comparison of Minimum Sample Size Requirements.
J Stroke Cerebrovasc Dis. 2022 Feb;31(2):106229. doi: 10.1016/j.jstrokecerebrovasdis.2021.106229. Epub 2021 Dec 3.
7
The Role of Selected Pro-Inflammatory Cytokines in Pathogenesis of Ischemic Stroke.
Clin Interv Aging. 2020 Mar 23;15:469-484. doi: 10.2147/CIA.S233909. eCollection 2020.
9
Neuroinflammation: friend and foe for ischemic stroke.
J Neuroinflammation. 2019 Jul 10;16(1):142. doi: 10.1186/s12974-019-1516-2.
10
Prognostic Value of C-Reactive Protein and Homocysteine in Large-Artery Atherosclerotic Stroke: a Prospective Observational Study.
J Stroke Cerebrovasc Dis. 2017 Mar;26(3):618-626. doi: 10.1016/j.jstrokecerebrovasdis.2016.11.016. Epub 2016 Dec 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验